Combined Dexamethasone Intravitreal Implant and Glaucoma Drainage Device Placement for Uveitic Glaucoma

PRECIS: At 1-year postoperative follow-up, concurrent placement of a dexamethasone intravitreal implant and glaucoma drainage device effectively controlled intraocular pressure (IOP) and inflammation in eyes with uveitic glaucoma with no changes in systemic immunomodulatory therapy. PURPOSE: The pur...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Tran, Kim, Han, Mielke, Christy, Momont, Anna C., Brandt, James D., Liu, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health, Inc 2020
Materias:
Original Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147398/
https://www.ncbi.nlm.nih.gov/pubmed/31990825
http://dx.doi.org/10.1097/IJG.0000000000001454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147398/
https://www.ncbi.nlm.nih.gov/pubmed/31990825
http://dx.doi.org/10.1097/IJG.0000000000001454

Ejemplares similares